Antibody Drug Conjugate Market Industry Trends and Forecasts to 2035, Featuring Profiles of Key Players ADC Therapeutics, Byondis, Daiichi Sankyo, Genentech, Gilead Sciences, ImmunoGen, RemeGen and More
26. November 2024 11:44 ET
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target...
Antibody Drug Conjugates Contract Manufacturing Market Analysis and Forecast (2025-2030) by Linker, Condition, End Use and Region - Industry Set to Experience 11.8% CAGR Over the Forecast Period
22. November 2024 07:14 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market by Linker, Condition, End Use - Global Forecast 2025-2030" report has been added to ...
Antibody Drug Conjugates (ADC) Industry Report 2024 - Advancements in Payload and Linker Technologies Generate Opportunities for Innovative ADC Products
05. November 2024 05:31 ET
|
Research and Markets
Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates (ADC) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Antibody...
Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche., Daiichi Sankyo, Pfizer, and Gilead Sciences
04. November 2024 07:00 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global sales of ADCs on...
Cancer Antibody Drug Conjugates Market, Drugs Approval & Clinical Trials Report 2024 - A US$ 50 Billion+ Market Opportunity By 2030
31. Oktober 2024 12:57 ET
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
Antibody Drug Conjugates Industry Report (2024-2032) Featuring Profiles the Top 13 Players - ADC Therapeutics, Astellas Pharma, AstraZeneca, Celldex Therapeutics, Roche & More
09. Oktober 2024 10:13 ET
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report by Component, Target, Application, End-user, and Region 2024-2032" report has been added to ...
Global Antibody Drugs Market Report 2024: Human Antibodies Segment, which Held the Largest Share in 2023, is Forecast to Grow at a CAGR of 13.4% During 2023-2029
23. September 2024 06:57 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for antibody drugs...
Degrader-Antibody Conjugates (DAC) Landscape Report 2024: Stakeholders, Platform Technologies, Development and Discovery Pipelines and Partnering Deals
10. September 2024 12:36 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective" report...
Antibody Drug Conjugates Market Insights 2018-2023 and Forecast to 2033 - Top 10 Players Dominate with 99.26% Share; Roche Leads with 36.24%, Followed by Daiichi Sankyo Company, and Seagen Inc.
12. Juli 2024 06:37 ET
|
Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.The global...
The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update): Anti-Obesity Medications Take Center Stage
03. Juli 2024 04:06 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)" report has been added to ResearchAndMarkets.com's offering.Although the...